Nutritional Effects in Cardiovascular Surgery
Nutritional Intervention in the Modulation of Postoperative Metabolism in Cardiovascular Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
This study aims to investigate the distribution of gut microbiota-derived metabolites, and to evaluate whether postoperative nutritional intervention can modulate the gut-heart metabolic axis, thereby improving metabolic profiles and clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 19, 2026
CompletedFirst Submitted
Initial submission to the registry
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 27, 2026
March 1, 2026
10 months
March 23, 2026
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Trimethylamine-N-oxide
Gut microbiota-derived metabolites
From enrollment to the end of intervention at 3 weeks
Phenylacetylglutamine
Gut microbiota-derived metabolites
From enrollment to the end of intervention at 3 weeks
P-cresyl sulfate
Gut microbiota-derived metabolites
From enrollment to the end of intervention at 3 weeks
Indoxyl sulfate
Gut microbiota-derived metabolites
From enrollment to the end of intervention at 3 weeks
Study Arms (2)
Probiotic group
EXPERIMENTALReceived standard postoperative care with probiotic supplementation
Placebo group
PLACEBO COMPARATORReceived standard postoperative care with placebo supplementation
Interventions
probiotic supplementation will be administered, while participants continue undergoing standard postoperative care
Undergo routine standard postoperative care with placebo intervention
Eligibility Criteria
You may qualify if:
- Scheduled to undergo cardiovascular surgery
- Completed preoperative clinical and imaging evaluations
- Willing to provide informed consent
- Willing to receive potential probiotic supplementation
You may not qualify if:
- Use of antibiotics, probiotics, or other treatments affecting gut microbiota within 4 weeks
- History of major gastrointestinal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, 24352, Taiwan
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Ke-Yun Chao, PhD
Fu Jen Catholic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 23, 2026
First Posted
March 27, 2026
Study Start
March 19, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share